Lobbying client
CURIE BIO OPERATIONS, LLC
Biopharmaceutical developer.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
6
Filed by
2
Reported in-house
—
Reported by firms
$380,000
Filings
6 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
ALSTON & BIRD LLP | $150,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
ALSTON & BIRD LLP | $130,000 reported |
|
2nd Quarter - Termination 2nd Quarter 2026
|
MARSHALL & POPP, LLC | $40,000 reported |
|
1st Quarter - Report 1st Quarter 2026
|
MARSHALL & POPP, LLC | $60,000 reported |
|
Registration 2nd Quarter 2026
|
ALSTON & BIRD LLP | — reported |
|
Registration 1st Quarter 2026
|
MARSHALL & POPP, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| ALSTON & BIRD LLP | 2 | $280,000 |
| MARSHALL & POPP, LLC | 2 | $100,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 6 |
| Budget/Appropriations | BUD | 3 |
| Financial Institutions/Investments/Securities | FIN | 2 |
| Banking | BAN | 2 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.